Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Adalimumab; ohne 80 mg; ATC-Code: L04AB04
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Adapalen 3 mg/g und Benzoylperoxid 25 mg/g ; ATC-Code: D10AD23 (ADV), D10AD53 (WHO)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Aflibercept; 40 mg/ml; ATC-Code: S01LA05
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Alglucosidase alfa; ATC-Code: A16AB07
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Bimatoprost; Wirkstärke 0,1 mg/ml; ATC-Code: S01EE03
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Biperiden; ATC-Code: N04AA02
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Brolucizumab; ATC-Code: S01LA06
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Budesonid; Magensaftresistente Hartkapseln; ATC-Code: A07EA06
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Dabrafenib; ATC-Code: L01EC02
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Dalteparin; ATC-Code: B01AB04
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Diazepam; ATC-Code: N05BA01
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Dimethylfumarat - zur Behandlung der schubförmig remittierenden MS; Wirkstärke 120 mg, Packungsgröße 28 HKM und 56 HKM (N2); Wirkstärke 240 mg, Packungsgröße 196 HKM (N3); ATC-Code: L04AX07
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Eisen, parenterale Darreichungsformen: Eisen(III)-hydroxid-Saccharose-Komplex; Eisen(III)-hydroxid-Dextran-Komplex; Eisen(III)-Natrium-D-gluconat-Komplex; Eisenderisomaltose; ATC-Code: B03AC02, B03AC06, B03AC07, B03AC08 (ADV); B03AC (WHO)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Epoetin alfa und Epoetin zeta; ATC-Code: B03XA01
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Etanercept; ATC-Code: L04AB01
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
June 30, 2026 at 10:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria